Welcome to the Epidemic Preparedness Innovations (EPI) web space. This platform has been set up by the Coalition for Epidemic Preparedness Innovations (CEPI). It aims to bring together knowledge, tools and methods to support vaccine researchers, developers, funders and anybody working on or interested in the field of epidemic preparedness innovations.
This news announcement forms part of CEPI’s 100 Days Mission, a campaign delving into how we can compress the vaccine development timeline to 100 days, while also counting down to CEPI’s Global Pandemic Preparedness Summit taking place in March, 2022. ... Read more
CEPI is pleased to announce a new funding opportunity for clinical trials with the aim to generate data on fractional doses of COVID-19 vaccines given as additional doses in primed populations. Read more
The largest ever study created and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) to provide a more accurate assessment of the incidence of Lassa fever infections has launched in several more countries in West Africa. Read more
IAVI has received an award of €22.8 million from the European & Developing Countries Clinical Trials Partnership (EDCTP) and the Coalition for Epidemic Preparedness Innovations (CEPI) to conduct a Phase IIb clinical trial of a novel vaccine candidate to prevent ... Read more
COVID-19 has touched all of our lives and changed our world beyond recognition. What comes next? ... Read more
See more here... Read more
